Surgical Treatment for Keratinocyte Skin Cancer Proves Safe in Octogenarians, Swiss Study Shows
核心洞察
A University Hospital of Zurich (搜索) study of 345 elderly patients demonstrates surgical removal of keratinocyte skin cancer (搜索) is safe and effective, with only 4.6% experiencing complications.
The research validates surgical intervention for large tumors exceeding 2cm in diameter, with most procedures successfully performed on an outpatient basis.
Patients using blood thinners, those with lower extremity tumors, and cases involving larger surgical specimens showed higher complication risks, though most resolved without additional intervention.
A comprehensive study from the University Hospital of Zurich (搜索) has validated the safety and efficacy of surgical intervention for keratinocyte skin cancer (搜索) (KC) in patients over 80 years old, challenging previous concerns about surgical risks in elderly populations.
The retrospective analysis, examining 565 tumor removals across 345 patients during 2022, revealed a remarkably low overall complication rate of 4.6%. Most complications were minor and resolved without additional medical intervention, supporting surgical treatment as a primary approach even for elderly patients with multiple or large tumors.
Surgical Outcomes and Patient Demographics
Nearly two-thirds of the study participants underwent single tumor removal, while the remaining third had between two to eight tumors excised. The majority of cases involved basal and squamous cell carcinomas, with approximately 25% classified as large tumors exceeding 2 cm in diameter.
"Our study demonstrates that patients, their families, and physicians need not avoid or fear surgical removal, even for larger KC of several centimeters in diameter," the research team emphasized. The findings particularly highlighted the success of outpatient procedures, with only 13.3% of cases requiring inpatient care.
Risk Factors and Complications
The study identified several key risk factors for post-operative complications, including:
- Use of novel oral anticoagulants (NOACs) or blood thinners
- Tumor location on lower extremities
- Surgical specimen sizes larger than 2 cm²
- Flap repairs in delicate areas
Wound dehiscence emerged as the most frequent complication, accounting for 58% of all reported issues. Other complications included infection, hematoma, hemorrhage, and necrosis, though most resolved without intervention.
Anticoagulation Management
The research highlighted particular challenges in managing anticoagulation therapy, with NOACs emerging as a significant risk factor despite being discontinued 24 hours before procedures. This finding underscores the complexity of perioperative care in elderly patients, who often manage multiple medications.
Clinical Implications
As life expectancy increases and KC becomes more prevalent among older populations, these findings provide valuable guidance for treatment decisions. The study supports timely surgical intervention as the most effective approach for managing KC in elderly patients, even in cases involving larger tumors or high-risk anatomical locations.
While the single-center nature of the study and its retrospective design present some limitations, the results provide compelling evidence for the safety and efficacy of surgical KC treatment in octogenarian patients. The findings suggest that age alone should not deter consideration of surgical intervention when clinically indicated.